TP03HN106 in Patients With Critical Limb Ischemia

Clinical trial NCT06482892 · RECRUITING

Trial details

NCT number: NCT06482892
Sponsor: Talengen Institute of Life Sciences, Shenzhen, P.R. China.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Critical Limb Ischemia

Start date: 2024-07-18
Primary completion: 2025-09-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.